Help develop new treatments for COVID-19

Home \ Help develop new treatments for COVID-19
HUJI - University of Manitoba - IMRIC

Our global community is facing unprecedented challenges as it fights a virulent health threat. While physical distancing has become the rule, the COVID-19 virus sends us a clear message: the only way out is through social togetherness and reciprocity.


We all want a sense of belonging and we, through CFHU, have a strong community and a feeling of being part of something greater that can help take care of us. This is a shared responsibility, knowing we depend on those who will help combat this pandemic and not only flatten the curve but disrupt its path, now and for future threats. In turn, they are depending on us.

Researchers at the Institute for Medical Research Israel-Canada (IMRIC) in Jerusalem, headed by Dr. Ofer Mandelboim, collaborating with Dr. Adrienne Meyers at the National Microbiology Laboratory in Winnipeg, are intensifying their investigations in their quest to find a cure for COVID-19.

Dr. Ofer Mandelboim
Dr. Adrienne Myers
Dr. Adrienne Myers

Since early 2009, these highly esteemed and renowned researchers have been working together to understand complex viruses to better approach such pathogens for development of vaccines and treatments.


Their work in isolating virus-specific cells and examining immune mechanisms and drug-resistance to antiretroviral therapies, for diseases such as HIV, influenza and dengue, are providing an incredible foundation for rapidly advancing research to develop new treatments against the coronavirus afflicting our world today.

Urgent needs, as a result of the SARS-CoV2/COVID-19 pandemic are best addressed by Dr. Meyers whose involvement in previous outbreak response related to virus infections, is informing her work on facilitating diagnostic and therapeutic developments to address the current outbreak. In concert with this are the exciting, recent products developed by Dr. Mandelboim and his team, which may provide a novel SARS-CoV2/COVID-19 treatment to help mitigate the often deadly nature of this virus. New, effective tools and treatments are urgently needed to curb the current and ongoing infections that are increasing daily.


  • Dr. Adrienne Ashira Meyers is Associate Director of the National HIV and Retrovirology Laboratories of the National Microbiology Laboratory, part of the Infectious Disease Prevention and Control Branch at the Public Health Agency of Canada, in Winnipeg, Canada.
  • Dr. Ofer Mandelboim is part of the Concern Foundation Laboratories of the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University Hadassah Medical School, Jerusalem, Israel.

We hope you will join us in supporting their research.

Make An Impact